CYTOMX THERAPEUTICS INC's ticker is and the CUSIP is 23284F955. A total of 2 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -98.0% | 300 | -96.2% | 0.00% | – |
| Q2 2021 | $51,000 | +5000.0% | 8,000 | +3900.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | -77.8% | 200 | -83.3% | 0.00% | – |
| Q3 2019 | $9,000 | -60.9% | 1,200 | +20.0% | 0.00% | – |
| Q2 2018 | $23,000 | -86.9% | 1,000 | -83.9% | 0.00% | -100.0% |
| Q1 2018 | $176,000 | +259.2% | 6,200 | +169.6% | 0.00% | – |
| Q4 2017 | $49,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 626 | $1,158,000 | 0.11% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |